[68GA]PSMA-HBED-CC

DRUG2 trials

Sponsors

Ospedale San Raffaele S.r.l.

Conditions

High-risk prostate cancerPatients with prostate cancer (PCa) who are candidate to undergo surgical treatment with robot-assisted radical prostatectomy with a risk of lymph nodal invasion > 5% according to preoperative data

Phase 2

An open label, single-arm, phase 2 study of neoadjuvant PEMbrolizumab before radical PROstatectomy (PEM-PRO) in high-risk prostate cancer patients

Not yet recruitingCTIS2024-514580-26-00

Ospedale San Raffaele S.r.l.High-risk prostate cancer

Target: 59Updated: 2024-10-08

The Role of Imaging Guided Surgery to Improve the Detection of Lymph Node metastases in Prostate Cancer Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection

CompletedCTIS2024-514583-12-00

Ospedale San Raffaele S.r.l.Patients with prostate cancer (PCa) who are candidate to undergo surgical treatment with robot-assisted radical prostatectomy with a risk of lymph nodal invasion > 5% according to preoperative data

Start: 2021-05-05End: 2024-12-10Target: 100Updated: 2024-11-11